Tag Archives: i-mak

India: Lopinavir+Ritonavir Abbott Application Rejected

Formulation patent application which covers Lopinavir+Ritonavir combination is rejected in India. This application was opposed by i-mak, Matrix, Cipla and Osaka. Application No: 339/MUMNP/2006 (National phase of WO2005/039551) Applicant: Abbott Opponents: i-mak, Cipla, Matrix, Osaka Interesting Note: This application is related … Continue reading

Posted in Patent case | Tagged , , , , , , | Leave a comment